FIELD: medicine.
SUBSTANCE: method involves introducing cultured neural embryo stem cells suspension at a dose of 1-2.5 mln in 0.05-0.1 ml of physiologic saline into vitreous body cavity or suprachoroid space of the eye.
EFFECT: enhanced effectiveness of treatment.
3 cl, 2 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INCREMENT IN RETINA CAPACITY WITH VARIOUS PATHOLOGIES | 2008 |
|
RU2364382C1 |
| METHOD FOR CORRECTING DYSTROPHIC CHANGES IN RETINA IN PATHOLOGIC CASES OF VARIOUS GENESIS | 2003 |
|
RU2238705C1 |
| METHOD FOR MODELING TOXIC RETINOPATHY | 2004 |
|
RU2284582C2 |
| METHOD FOR TREATING CORNEA DEFECT CASES | 2004 |
|
RU2279887C2 |
| METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2727000C1 |
| METHOD FOR PREDICTING RETINAL NEOVASCULARIZATION IN CASE OF DIABETIC RETINOPATHY | 2004 |
|
RU2263462C1 |
| METHOD OF TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM INDUCED HUMAN PLURIPOTENT STEM CELLS, WITH RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2730937C1 |
| METHOD OF SUBRETINAL TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, WITH ATROPHY OF RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2019 |
|
RU2729937C1 |
| METHOD FOR STUDYING BIOLOGICAL ACTION OF POTENTIAL BIOMEDICAL CELL PRODUCTS BASED ON HUMAN CELLS IN SUBRETINAL XENOGENEIC TRANSPLANTATION IN EXPERIMENT | 2024 |
|
RU2830558C1 |
| METHOD FOR MODELING RETINOPATHY | 2004 |
|
RU2260856C1 |
Authors
Dates
2006-07-20—Published
2004-06-10—Filed